Published in Proteins on May 01, 1993
Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J (1994) 3.68
Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc Natl Acad Sci U S A (1998) 2.32
Single-domain antibody fragments with high conformational stability. Protein Sci (2002) 2.31
Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J (1998) 2.30
The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5. J Virol (2004) 2.02
IgG subclasses and allotypes: from structure to effector functions. Front Immunol (2014) 1.95
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol (2009) 1.94
Comparison of antibody repertoires produced by HIV-1 infection, other chronic and acute infections, and systemic autoimmune disease. PLoS One (2011) 1.68
Antigen recognition by variable lymphocyte receptors. Science (2008) 1.61
Synthetic antibodies for specific recognition and crystallization of structured RNA. Proc Natl Acad Sci U S A (2007) 1.51
Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library. Proc Natl Acad Sci U S A (1995) 1.45
Repertoire-based selection into the marginal zone compartment during B cell development. J Exp Med (2008) 1.36
Kabat database and its applications: 30 years after the first variability plot. Nucleic Acids Res (2000) 1.36
Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan. Infect Immun (1994) 1.34
Third complementarity-determining region of mutated VH immunoglobulin genes contains shorter V, D, J, P, and N components than non-mutated genes. Immunology (2001) 1.30
Teaching an old scaffold new tricks: monobodies constructed using alternative surfaces of the FN3 scaffold. J Mol Biol (2011) 1.29
Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response. Proc Natl Acad Sci U S A (2013) 1.26
Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses. J Virol (2004) 1.25
Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display. Proc Natl Acad Sci U S A (1996) 1.21
Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics. Virology (2008) 1.11
A compact phage display human scFv library for selection of antibodies to a wide variety of antigens. BMC Biotechnol (2009) 1.08
A humanized anti-VEGF rabbit monoclonal antibody inhibits angiogenesis and blocks tumor growth in xenograft models. PLoS One (2010) 1.08
Inferring processes underlying B-cell repertoire diversity. Philos Trans R Soc Lond B Biol Sci (2015) 1.06
Structural evidence for evolution of shark Ig new antigen receptor variable domain antibodies from a cell-surface receptor. Proc Natl Acad Sci U S A (2004) 1.06
Generating conformation-specific synthetic antibodies to trap proteins in selected functional states. Methods (2012) 1.06
Multi-constraint computational design suggests that native sequences of germline antibody H3 loops are nearly optimal for conformational flexibility. Proteins (2009) 1.05
Structural insight into distinct mechanisms of protease inhibition by antibodies. Proc Natl Acad Sci U S A (2007) 1.05
Understanding the bacterial polysaccharide antigenicity of Streptococcus agalactiae versus Streptococcus pneumoniae. Proc Natl Acad Sci U S A (2006) 1.04
Nanobody: the "magic bullet" for molecular imaging? Theranostics (2014) 1.04
Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity. J Virol (2015) 1.01
Natural and man-made V-gene repertoires for antibody discovery. Front Immunol (2012) 0.98
The human IgE repertoire. Int Arch Allergy Immunol (2013) 0.94
Superantigen properties of a human sialoprotein involved in gut-associated immunity. J Clin Invest (1995) 0.93
A reverse binding motif that contributes to specific protease inhibition by antibodies. J Mol Biol (2011) 0.91
A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries. Proc Natl Acad Sci U S A (1998) 0.90
Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies Against HIV-1. Front Immunol (2014) 0.88
Transferring the characteristics of naturally occurring and biased antibody repertoires to human antibody libraries by trapping CDRH3 sequences. PLoS One (2012) 0.88
A directed molecular evolution approach to improved immunogenicity of the HIV-1 envelope glycoprotein. PLoS One (2011) 0.87
Modeling the binding sites of anti-hen egg white lysozyme antibodies HyHEL-8 and HyHEL-26: an insight into the molecular basis of antibody cross-reactivity and specificity. Biophys J (2003) 0.87
Botulinum neurotoxins and botulism: a novel therapeutic approach. Toxins (Basel) (2011) 0.86
Effect of epitope position on neutralization by anti-human immunodeficiency virus monoclonal antibody 2F5. J Virol (2006) 0.86
Transplantation of a 17-amino acid alpha-helical DNA-binding domain into an antibody molecule confers sequence-dependent DNA recognition. Proc Natl Acad Sci U S A (1995) 0.85
The V gene repertoires of classical and atypical memory B cells in malaria-susceptible West African children. J Immunol (2015) 0.84
Hyperimmune bovine colostrum as a low-cost, large-scale source of antibodies with broad neutralizing activity for HIV-1 envelope with potential use in microbicides. Antimicrob Agents Chemother (2012) 0.82
OptMAVEn--a new framework for the de novo design of antibody variable region models targeting specific antigen epitopes. PLoS One (2014) 0.82
The invention of lymphocytes. Curr Opin Immunol (2011) 0.82
Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus Macaques. Vaccines (Basel) (2013) 0.81
HIV-2 neutralization by intact V3-specific Fab fragments. Virol J (2008) 0.81
Humoral alloimmunity in transplantation: relevance of HLA epitope antigenicity and immunogenicity. Front Immunol (2011) 0.80
Molecular basis of recognition of human osteopontin by 23C3, a potential therapeutic antibody for treatment of rheumatoid arthritis. J Mol Biol (2008) 0.79
Production and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressing human immunoglobulins. Clin Vaccine Immunol (2006) 0.79
Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries. Proc Natl Acad Sci U S A (2016) 0.78
Analysis and modeling of the variable region of camelid single-domain antibodies. J Immunol (2011) 0.78
Trimeric gp120-specific bovine monoclonal antibodies require cysteine and aromatic residues in CDRH3 for high affinity binding to HIV Env. MAbs (2016) 0.78
Crystal structure of the HIV-2 neutralizing Fab fragment 7C8 with high specificity to the V3 region of gp125. PLoS One (2011) 0.76
Usefulness of the Nonself-Self Algorithm of HLA Epitope Immunogenicity in the Specificity Analysis of Monospecific Antibodies Induced during Pregnancy. Front Immunol (2015) 0.76
Production, purification, crystallization and preliminary X-ray diffraction analysis of the HIV-2-neutralizing V3 loop-specific Fab fragment 7C8. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.76
Lessons learned from human HIV vaccine trials. Curr Opin HIV AIDS (2017) 0.75
Generation of a highly reactive chicken-derived single-chain variable fragment against Fusarium verticillioides by phage display. Int J Mol Sci (2012) 0.75
Anti-anti-idiotypic (Ab3) antibodies that bind progesterone-11alpha-bovine serum albumin differ in their combining sites from antibodies raised directly against the antigen. Immunology (2000) 0.75
Engineered Autonomous Human Variable Domains. Curr Pharm Des (2016) 0.75
Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis. Oncotarget (2016) 0.75
Structural models of antibody variable fragments: a method for investigating binding mechanisms. J Comput Aided Mol Des (1998) 0.75
Detection of specific hybridoma clones by replica immunoadsorption of their secreted antibodies. Proc Natl Acad Sci U S A (1979) 13.60
FRACTIONATION OF SERUM PROTEINS IN HYPERPROTEINEMIA, WITH SPECIAL REFERENCE TO MULTIPLE MYELOMA. J Clin Invest (1941) 11.64
An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med (1970) 9.83
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med (1991) 8.65
A histochemical study of the distribution of alkaline phosphatase in various normal and neoplastic tissues. Am J Pathol (1941) 7.24
Blindness and visual impairment in southern Malawi. Bull World Health Organ (1986) 6.07
An exploration of the sequence of a 2.9-Mb region of the genome of Drosophila melanogaster: the Adh region. Genetics (1999) 5.87
Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers. J Exp Med (1968) 5.72
ASSOCIATION OF PHOSPHATASE WITH A MATERIAL IN KIDNEY SEDIMENTABLE AT HIGH SPEED AND ITS LIBERATION BY AUTOLYSIS. Science (1941) 5.22
CHEMICAL STUDIES ON BACTERIAL AGGLUTINATION : I. A METHOD. J Exp Med (1934) 4.84
Increased costs and rates of use in the California workers' compensation system as a result of self-referral by physicians. N Engl J Med (1992) 4.65
The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med (1989) 4.41
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene (2012) 4.30
Spin warp NMR imaging and applications to human whole-body imaging. Phys Med Biol (1980) 4.05
Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci U S A (1993) 3.66
HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int (1994) 3.60
Observations of intergranular stress corrosion cracking in a grain-mapped polycrystal. Science (2008) 3.53
AN ELECTROPHORETIC STUDY OF IMMUNE SERA AND PURIFIED ANTIBODY PREPARATIONS. J Exp Med (1939) 3.48
ISOLATION OF TRICHOMONAS VAGINALIS WITH PENICILLIN. Science (1945) 3.45
Histochemical Studies on Tissue Enzymes: III. A Study of the Distribution of Acid Phosphatases with Special Reference to the Nervous System. Am J Pathol (1943) 3.31
The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain (1987) 3.15
Rapid Production of Acute Disseminated Encephalomyelitis in Rhesus Monkeys by Injection of Brain Tissue With Adjuvants. Science (1946) 2.88
The nature of an antigenic determinant. J Immunol (1966) 2.85
A QUANTITATIVE STUDY OF THE CROSS REACTION OF TYPES III AND VIII PNEUMOCOCCI IN HORSE AND RABBIT ANTISERA. J Exp Med (1937) 2.74
The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell (1997) 2.57
Fat suppression in MR imaging: techniques and pitfalls. Radiographics (1999) 2.56
CHEMICAL STUDIES ON BACTERIAL AGGLUTINATION : III. A REACTION MECHANISM AND A QUANTITATIVE THEORY. J Exp Med (1937) 2.53
CHEMICAL STUDIES ON BACTERIAL AGGLUTINATION : II. THE IDENTITY OF PRECIPITIN AND AGGLUTININ. J Exp Med (1936) 2.52
Three-dimensional grain mapping by x-ray diffraction contrast tomography and the use of Friedel pairs in diffraction data analysis. Rev Sci Instrum (2009) 2.49
AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. Biochem J (1998) 2.45
The spectrum of renal disease in Laurence-Moon-Biedl syndrome. N Engl J Med (1988) 2.36
Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med (2001) 2.34
The Columbia University single-ion microbeam. Radiat Res (2001) 2.31
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain (1988) 2.29
Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology (1999) 2.26
Blindness in the developing world. Br J Ophthalmol (1993) 2.26
Causes of suppurative keratitis in Ghana. Br J Ophthalmol (1995) 2.17
ASSOCIATION OF THE WASSERMANN ANTIGEN WITH HEAVY MATERIALS PRESENT IN TISSUES. Science (1941) 2.17
Relation of Chlorogenic Acid to Scab Resistance in Potatoes. Science (1952) 2.08
IMMUNOCHEMICAL STUDIES ON BLOOD GROUPS : III. PROPERTIES OF PURIFIED BLOOD GROUP A SUBSTANCES FROM INDIVIDUAL HOG STOMACH LININGS. J Exp Med (1946) 2.02
A survey of the pharmacological properties of metoprolol in animals and man. Acta Pharmacol Toxicol (Copenh) (1975) 2.01
QUANTITATIVE STUDIES ON ANTIBODY PURIFICATION : II. THE DISSOCIATION OF ANTIBODY FROM PNEUMOCOCCUS SPECIFIC PRECIPITATES AND SPECIFICALLY AGGLUTINATED PNEUMOCOCCI. J Exp Med (1938) 2.01
Purification and characterization of a lectin (plant hemagglutinin) with blood group A specificity from Dolichos biflorus. Biochemistry (1970) 2.01
The balance between isoforms of the prickle LIM domain protein is critical for planar polarity in Drosophila imaginal discs. Genes Dev (1999) 1.98
THE MOLECULAR WEIGHTS OF ANTIBODIES. Science (1938) 1.98
Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group. J Card Fail (1999) 1.96
Magnetic resonance imaging in isolated noncompressive spinal cord syndromes. Ann Neurol (1987) 1.93
Variable region genes for the immunoglobulin framework are assembled from small segments of DNA--a hypothesis. Proc Natl Acad Sci U S A (1978) 1.92
Immunochemical studies on the specificity of the peanut (Arachis hypogaea) agglutinin. Carbohydr Res (1976) 1.88
Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas. AJNR Am J Neuroradiol (2006) 1.87
Implantable transvenous cardioverter-defibrillators. Circulation (1993) 1.87
BENCE-JONES PROTEINEMIA IN MULTIPLE MYELOMA. J Clin Invest (1943) 1.86
Changes in the structure of wages in the 1980's: an evaluation of alternative explanations. Am Econ Rev (1992) 1.84
Attempts to locate complementarity-determining residues in the variable positions of light and heavy chains. Ann N Y Acad Sci (1971) 1.84
White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res (2001) 1.76
IMMUNOLOGICAL SPECIFICITY OF MATERIAL SEDIMENTABLE AT HIGH SPEED PRESENT IN NORMAL AND TUMOR TISSUES. J Exp Med (1941) 1.73
Acute childhood encephalitis and Mycoplasma pneumoniae. Clin Infect Dis (2001) 1.72
A FURTHER STUDY OF THE CROSS REACTION BETWEEN THE SPECIFIC POLYSACCHARIDES OF TYPES III AND VIII PNEUMOCOCCI IN HORSE ANTISERA. J Exp Med (1942) 1.70
CHEMICAL STUDIES ON BACTERIAL AGGLUTINATION : IV. QUANTITATIVE DATA ON PNEUMOCOCCUS R (DAWSON S)- ANTI-R (S) SYSTEMS. J Exp Med (1938) 1.66
ELECTROPHORESIS OF IMMUNE SERUM. Science (1938) 1.65
Immunochemical studies on the combining site of the blood group H-specific lectin 1 from Ulex europeus seeds. Arch Biochem Biophys (1978) 1.65
Studies on specificity and binding properties of the blood group A reactive hemagglutinin from Helix pomatia. Biochemistry (1971) 1.61
Acupuncture treatment of patients with radiation-induced xerostomia. Eur J Cancer B Oral Oncol (1996) 1.61
Mosquito surveillance and polymerase chain reaction detection of West Nile virus, New York State. Emerg Infect Dis (2001) 1.60
ASSOCIATION OF THE HETEROGENETIC ANTIGEN WITH A MATERIAL IN NORMAL AND TUMOR TISSUES SEDIMENTABLE AT HIGH SPEED. Science (1940) 1.59
Binding properties of immunoglobulin combining sites specific for terminal or nonterminal antigenic determinants in dextran. J Exp Med (1975) 1.57
Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol (2007) 1.57
Immunochemical studies on blood groups. XLI. Proposed structures for the carbohydrate portions of blood group A, B, H, Lewis-a, and Lewis-b substances. Proc Natl Acad Sci U S A (1968) 1.57
Hyperoxaluria in patients with ileal resection: an abnormality in dietary oxalate absorption. Gastroenterology (1974) 1.54
Monitoring serum theophylline levels. Clin Pharmacokinet (1978) 1.54
Hemodynamic changes with cirrhosis of the liver: control of arteriovenous shunts during operation for esophageal varices. Ann Surg (1966) 1.53
Strategies for syphilis prevention: findings from surveys in a high-incidence area. Sex Transm Dis (2000) 1.52
Chronic anxiety treated by feedback-induced muscle relaxation. A pilot study. Arch Gen Psychiatry (1973) 1.51
Purification and characterization of a blood-group A reactive hemagglutinin from the snail Helix pomatia and a study of its combining site. Biochemistry (1969) 1.50
Immunochemical similarities between monoclonal antibacterial Waldenstrom's macroglobulins and monoclonal anti-DNA lupus autoantibodies. J Exp Med (1985) 1.49
Unusual distributions of amino acids in complementarity-determining (hypervariable) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody-combining sites. J Biol Chem (1977) 1.48
Structure of the bacteriophage lambda cohesive end site: location of the sites of terminase binding (cosB) and nicking (cosN). Gene (1983) 1.48
Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology (1988) 1.46
Central venous access in morbidly obese patients. Anesth Analg (2001) 1.45
Immunochemical studies on blood groups. XXXIV. Structures of some oligosaccharides produced by alkaline degradation of blood group A, B, and H substances. Biochemistry (1966) 1.45
Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med (2001) 1.43
Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol (2001) 1.42
Mononuclear cell-mediated enhancement of granulocyte function in man. J Immunol (1984) 1.42
Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation (1993) 1.42
Immunochemical studies on blood groups. XLVII. The I antigen complex--precursors in the A, B, H, Lea, and leb blood group system--hemagglutination-inhibition studies. J Exp Med (1971) 1.41
Cellular reactivity to Candida albicans antigen. N Engl J Med (1966) 1.41
Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation (1993) 1.41
JEM spotlight: Environmental monitoring of airborne nanoparticles. J Environ Monit (2009) 1.40
Emissions from a vehicle fitted to operate on either petrol or compressed natural gas. Sci Total Environ (2004) 1.38
Comparative analysis of hematopoietic growth factors released by stromal cells from normal donors or transplanted patients. Blood (1990) 1.38
Interactions of fluorochrome-labeled caspase inhibitors with apoptotic cells: a caution in data interpretation. Cytometry A (2003) 1.37
Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Am J Physiol (1990) 1.37
Misdiagnosis of ruptured abdominal aortic aneurysms. J Vasc Surg (1992) 1.37
Immunochemical studies on mouse myeloma proteins reactive with dextrans or with fructosans and on human antilevans. J Exp Med (1974) 1.36
Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. Clin Infect Dis (2012) 1.36
Immunochemical studies on mouse myeloma proteins with specificity for dextran or for levan. Immunochemistry (1972) 1.35